| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communications |
Background: Chemopreventive agents developed to be used in a moderate-risk but otherwise healthy population need to be both efficacious and to have minimal adverse effects.
Objective: The objective of this study was to evaluate the adverse effects of long-term retinol intake in a skin cancer chemoprevention trial in a large population at moderate risk for skin cancer.
Design: Participants (n = 2297) were randomly assigned to receive retinol [7576 retinol equivalents (RE), or 25000 IU] or a placebo daily. The adverse effects of retinol intake were studied by monitoring 14 clinical symptoms and laboratory indexes. The median follow-up time was 3.8 y.
Results: No adverse effects concerning the 14 symptoms were observed. Significant differences in alkaline phosphatase (P < 0.0001), triacylglycerol (P < 0.0001), cholesterol (P = 0.04), and HDL (P = 0.01) were observed over time between the 2 groups. After 49 mo of follow-up, alkaline phosphatase was 7% higher, triacylglycerol was 11% higher, cholesterol was 3% higher, and HDL was 1% lower in the retinol group than in the placebo group.
Conclusions: Because a 1% increase in cholesterol concentrations has been reported to be associated with a 2% increase in coronary artery disease risk, long-term ingestion of 7576 RE vitamin A/d should be considered with caution. However, further studies are needed to confirm this finding.
Key Words: Retinol • skin cancer • prevention • actinic keratoses • humans • long-term effects • Arizona • adults
This article has been cited by other articles:
|
|
 |
|
  D. Alberts, J. Ranger-Moore, J. Einspahr, K. Saboda, P. Bozzo, Y. Liu, X.-c. Xu, R. Lotan, J. Warneke, S. Salasche, et al. Safety and Efficacy of Dose-Intensive Oral Vitamin A in Subjects with Sun-Damaged Skin Clin. Cancer Res., March 15, 2004; 10(6): 1875 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Mayne, B. Cartmel, H. Lin, T. Zheng, and W. J. Goodwin Jr Low Plasma Lycopene Concentration is Associated with Increased Mortality in a Cohort of Patients with Prior Oral, Pharynx or Larynx Cancers J. Am. Coll. Nutr., February 1, 2004; 23(1): 34 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Lawrence, P. C. Adamson, R. Caruso, C. Chow, D. Kleiner, R. F. Murphy, D. J. Venzon, M. Shovlin, M. Noone, M. Merino, et al. Phase I Clinical Trial of Alitretinoin and Tamoxifen in Breast Cancer Patients: Toxicity, Pharmacokinetic, and Biomarker Evaluations J. Clin. Oncol., May 15, 2001; 19(10): 2754 - 2763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ballew, B. A Bowman, R. M Russell, A. L Sowell, and C. Gillespie Serum retinyl esters are not associated with biochemical markers of liver dysfunction in adult participants in the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 Am. J. Clinical Nutrition, May 1, 2001; 73(5): 934 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, et al. Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer J Natl Cancer Inst, April 18, 2001; 93(8): 605 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Cartmel, T. E. Moon, N. Levine, S. Rodney, and D. Alberts Predictors of Inactivation and Reasons for Participant Inactivation during a Skin Cancer Chemoprevention Study Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 999 - 1002. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. D. Dawson, Y. Yamamoto, R. Zolfaghari, F. J. Rosales, J. Dietz, T. Shimada, N.-q. Li, and A. C. Ross Regulation of Hepatic Vitamin A Storage in a Rat Model of Controlled Vitamin A Status during Aging J. Nutr., May 1, 2000; 130(5): 1280 - 1286. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
